Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion type Assertion NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_head.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion description "[Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) that have poor prognosis and very few identified molecular targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_provenance.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion evidence source_evidence_literature NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_provenance.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion SIO_000772 24634415 NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_provenance.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion wasDerivedFrom befree-2016 NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_provenance.
- NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_assertion wasGeneratedBy ECO_0000203 NP1164535.RAGeWpanD2dGPUNjINSWphB4Gd4Lk5jFyXy_r1BYudjiI130_provenance.